Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Imidazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Imidazole SCHEMBL29411697 | 1.00 | ALDH1A1 (0.65) | — | |
| Imidazole SCHEMBL30320112 | 1.00 | ALDH1A1 (0.65) | — | |
| Imidazole SCHEMBL28966030 | 1.00 | ALDH1A1 (0.65) | — | |
| Imidazole SCHEMBL29188028 | 0.98 | ALDH1A1 (0.62) | — | |
| Imidazole SCHEMBL29365438 | 0.98 | ALDH1A1 (0.62) | — | |
| Imidazole SCHEMBL28213689 | 0.98 | ALDH1A1 (0.62) | — | |
| Imidazole SCHEMBL2256134 | 0.98 | ALDH1A1 (0.62) | — | |
| Imidazole SCHEMBL3639063 | 0.98 | ALDH1A1 (0.62) | — | |
| Imidazole SCHEMBL28796723 | 0.98 | ALDH1A1 (0.62) | — | |
| Imidazole SCHEMBL27735299 | 0.98 | ALDH1A1 (0.62) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1789 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122059636-A | High slump-retaining type polycarboxylate superplasticizer and preparation method thereof | 广东六合新型建材有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4701438-A1 | COMPOSITIONS AND METHODS FOR IMPROVING METABOLIC HEALTH | Société des Produits Nestlé S.A. (CH) | 2026-03-04 | — | — | EP | claimed |
| EP-4701439-A1 | COMPOSITIONS AND METHODS FOR IMPROVING BRAIN HEALTH | Société des Produits Nestlé S.A. (CH) | 2026-03-04 | — | — | EP | claimed |
| US-12404224-B2 | Process for separating components of azeotropic mixtures using ionic liquids | UNIVERSITY OF KANSAS (US) | 2025-09-02 | — | — | US | claimed |
| WO-2025137293-A2 | ENHANCEMENT OF NUCLEIC ACID POLYMERIZATION BY AROMATIC COMPOUNDS | Roche Sequencing Solutions, Inc. (US) | 2025-06-26 | — | — | WO | claimed |
| CN-120079135-A | Ionic liquid dissolvent mixture and preparation method and application thereof | 浙江蓝德能源科技发展有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-116355015-B | Preparation method of zoledronic acid | 常州方圆制药有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-119816897-A | Multiple study assessment | 普罗科技有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119612552-A | Preparation method of hollow Prussian blue positive electrode material | 浙江山高新能源有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-119570482-A | Bi3+、Yb3+Co-doped Cs2ZrCl6Double perovskite microcrystal and preparation method of light conversion film thereof | 北京工业大学 | 2025-03-07 | — | — | CN | claimed |
| WO-2002102815-A2 | METHODS FOR PREPARING OLIGONUCLEOTIDES HAVING CHIRAL PHOSPHOROTHIOATE LINKAGES | ISIS PHARMACEUTICALS, INC. (US) | 2002-12-27 | — | — | WO | claimed |
| US-6495350-B1 | AMPLIFICATION OF NUCLEIC ACID MOLECULES BY REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION; MOLONEY MURINE LEUKEMIA VIRUS REVERSE TRANSCRIPTASE, ONE OR MORE DNA POLYMERASES, AND ONE OR MORE SULFUR-CONTAINING MOLECULES | INVITROGEN CORPORATION | 2002-12-17 | — | — | US | claimed |
| EP-0975806-A1 | COMPOSITIONS AND METHODS FOR REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION (RT-PCR) | Life Technologies, Inc. (US) | 2000-02-02 | — | — | EP | claimed |
| WO-1998044161-A9 | COMPOSITIONS AND METHODS FOR REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION (RT-PCR) | — | 1999-03-11 | — | — | WO | claimed |
| WO-1998044161-A1 | COMPOSITIONS AND METHODS FOR REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION (RT-PCR) | LIFE TECHNOLOGIES, INC. (US) | 1998-10-08 | — | — | WO | claimed |
| US-5723482-A | CARNOSINE OR DERIVATIVE, UROCANIC ACID OR DERIVATIVE | BEIERSDORF AG (DE) | 1998-03-03 | — | — | US | claimed |
| EP-0059156-B1 | PROCESS FOR THE PREPARATION OF IMIDAZOLEACETIC-ACID DERIVATIVES | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-04-23 | — | — | EP | claimed |
| EP-0015437-B1 | METHOD AND REAGENT FOR THE DETERMINATION OF CREATINE KINASE | Roche Diagnostics GmbH (DE) | 1981-11-25 | — | — | EP | claimed |
| US-4286057-A | QUANTITATIVE ANALYSIS OF CREATINE KINASE USING THE LUMINESCENT SYSTEM OF THE FIREFLY | BOEHRINGER MANNHEIM GMBH (DE) | 1981-08-25 | — | — | US | claimed |
| US-4067775-A | Process and composition for determining the activity of creatinekinase-MB | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1978-01-10 | — | — | US | claimed |